Here are 4 key messages of #FORCE17, which held its 10th anniversary conference last week on hereditary cancer issues.
- One-step and done? Nearly all breast reconstruction is not. Beware too, of scarless mastectomies claims.
- Breast reconstruction options for larger-framed women are improving. Now 3 of 10 women get nipple-sparing operations.
- Expect more gene discoveries in the next year or two that identify the deadliest tumors needing more aggressive treatment for prostate, pancreatic and other cancers where hereditary plays a role.
- Men need genetics testing too.
Summarized by Patricia Anstett, author, “Breast Cancer Surgery and Reconstruction: What’s Right for You,” from presentations at the conference of Facing Our Risk Empowered (FORCE).